Cao Y, Shi F, Li Y, Wei X, Yi H, Han S. Cost-effectiveness analysis of the combination of low-dose nivolumab with triple metronomic chemotherapy for advanced head and neck squamous cell carcinoma in China. Health Decision [Internet]. 2024 Jul. 12 [cited 2025 May 2];2(S1). Available from: https://www.hksmp.com/journals/hd/article/view/654